AOBR Radiology study materials
AOBR Radiology study resources

Acute Limb Ischemia in a Patient on Anticoagulation

AOBR Radiology · Put your knowledge to work in context.

All case studies

Acute Limb Ischemia in a Patient on Anticoagulation

A 74-year-old man with atrial fibrillation (on apixaban, last dose 8 hours ago), hypertension, and a prior femoropopliteal bypass graft presents with 6 hours of sudden-onset severe right leg pain, pallor, and paresthesias. He has no motor deficit. On examination the right foot is cool, the dorsalis pedis and posterior tibial pulses are absent, and capillary refill is prolonged. Ankle-brachial index is 0.35 on the right. He is afebrile with a normal white count. Duplex ultrasound shows occlusion of the native superficial femoral artery proximal to the graft anastomosis with no flow in the graft. The vascular surgery team is requesting catheter-directed therapy versus open thrombectomy.

1. How would you classify the severity of this ischemia, and what does that imply for urgency and choice of intervention?

Read the worked answer

This is Rutherford class IIb (or borderline IIa/IIb) acute limb ischemia: sudden onset, rest pain, pallor, paresthesias, absent pulses, and ABI 0.35, but no motor deficit and no fixed mottling. The presence of sensory deficit without motor deficit places it at the threatened limb stage. Class IIb is a threatened limb requiring urgent revascularization, generally within hours.

Because there is no motor deficit, there is a short window in which catheter-directed thrombolysis or pharmacomechanical thrombectomy is reasonable, provided the bleeding risk is acceptable. However, he received apixaban 8 hours ago. Systemic thrombolysis is relatively contraindicated in the setting of recent direct oral anticoagulant therapy; catheter-directed therapy at reduced dose may still be considered, but many operators would favor prompt surgical thrombectomy or mechanical thrombectomy alone to avoid lytic bleeding risk. The decision hinges on bleeding risk, duration of ischemia (6 hours is favorable), and the presence of a bypass graft, which is a classic substrate for acute thrombosis.

The key judgment: do not delay revascularization for a full coagulopathy workup in a threatened limb, but do not reflexively give full-dose lytics in a patient on a DOAC.

2. What imaging would you obtain before intervention, and what would you specifically want to know?

Read the worked answer

Duplex ultrasound already confirms occlusion. If the patient can tolerate it and there is no contraindication, CT angiography of the right lower extremity (or catheter-directed angiography at the time of intervention) is the next step. The specific questions are:

  1. Level of occlusion - is it confined to the native SFA, or does it extend into the graft and runoff?
  2. Status of the graft and the distal runoff vessels - a thrombosed graft with poor runoff has a much higher failure rate and may argue for surgical revision rather than lysis.
  3. Presence of a popliteal aneurysm or embolic source - atrial fibrillation raises the possibility of embolus, which changes the target (embolectomy vs. thrombolysis).
  4. Any contraindication to contrast (renal function) - relevant given his age and hypertension.

In a Rutherford IIb limb, imaging should not delay revascularization. If CTA can be obtained within 30–60 minutes, it is useful; otherwise proceed to the angiography suite, where diagnostic angiography and therapy can be combined.